Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study
Abstract Background The goal of the proposed study was to validate a rapid, simple, an accurate, robust, and sensitive bioanalytical method for quantifying Meloxicam and Lornoxicam (as internal standard) in rabbit plasma. Result Limit of detection and limit of quantification for Meloxicam were found...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-09-01
|
Series: | Future Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s43094-020-00069-3 |
id |
doaj-f383eb45d8d344d7929dc9503d78b736 |
---|---|
record_format |
Article |
spelling |
doaj-f383eb45d8d344d7929dc9503d78b7362020-11-25T03:57:43ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532020-09-016111210.1186/s43094-020-00069-3Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic studyNitin Salunkhe0Namdeo Jadhav1Somnath Bhinge2Department of Pharmaceutics, Bharati Vidyapeeth College of PharmacyDepartment of Pharmaceutics, Bharati Vidyapeeth College of PharmacyRajarambapu College of PharmacyAbstract Background The goal of the proposed study was to validate a rapid, simple, an accurate, robust, and sensitive bioanalytical method for quantifying Meloxicam and Lornoxicam (as internal standard) in rabbit plasma. Result Limit of detection and limit of quantification for Meloxicam were found to be 0.0081 and 0.1035 μg mL−1, respectively. The bioanalysis was continued according to standard guidelines and successfully used for bioavailability studies of meloxicam after single dose administration of pure drug and the formulation in rabbit plasma. Finally, obtained results proved its simplicity and an efficiency to be applied for the therapeutic drug monitoring and bioequivalence studies. Conclusion Therefore, the set RP-HPLC bioanalysis is simple, convenient, and acceptable to analyze meloxicam in bulk and pharmaceutical formulations in rabbit plasma. Graphical abstracthttp://link.springer.com/article/10.1186/s43094-020-00069-3BioanalysisMeloxicamLornoxicamValidationPharmacokinetic StudyRabbit Plasma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nitin Salunkhe Namdeo Jadhav Somnath Bhinge |
spellingShingle |
Nitin Salunkhe Namdeo Jadhav Somnath Bhinge Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study Future Journal of Pharmaceutical Sciences Bioanalysis Meloxicam Lornoxicam Validation Pharmacokinetic Study Rabbit Plasma |
author_facet |
Nitin Salunkhe Namdeo Jadhav Somnath Bhinge |
author_sort |
Nitin Salunkhe |
title |
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study |
title_short |
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study |
title_full |
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study |
title_fullStr |
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study |
title_full_unstemmed |
Meloxicam quantification in rabbit plasma by RP-HPLC: optimization and application to pharmacokinetic study |
title_sort |
meloxicam quantification in rabbit plasma by rp-hplc: optimization and application to pharmacokinetic study |
publisher |
SpringerOpen |
series |
Future Journal of Pharmaceutical Sciences |
issn |
2314-7253 |
publishDate |
2020-09-01 |
description |
Abstract Background The goal of the proposed study was to validate a rapid, simple, an accurate, robust, and sensitive bioanalytical method for quantifying Meloxicam and Lornoxicam (as internal standard) in rabbit plasma. Result Limit of detection and limit of quantification for Meloxicam were found to be 0.0081 and 0.1035 μg mL−1, respectively. The bioanalysis was continued according to standard guidelines and successfully used for bioavailability studies of meloxicam after single dose administration of pure drug and the formulation in rabbit plasma. Finally, obtained results proved its simplicity and an efficiency to be applied for the therapeutic drug monitoring and bioequivalence studies. Conclusion Therefore, the set RP-HPLC bioanalysis is simple, convenient, and acceptable to analyze meloxicam in bulk and pharmaceutical formulations in rabbit plasma. Graphical abstract |
topic |
Bioanalysis Meloxicam Lornoxicam Validation Pharmacokinetic Study Rabbit Plasma |
url |
http://link.springer.com/article/10.1186/s43094-020-00069-3 |
work_keys_str_mv |
AT nitinsalunkhe meloxicamquantificationinrabbitplasmabyrphplcoptimizationandapplicationtopharmacokineticstudy AT namdeojadhav meloxicamquantificationinrabbitplasmabyrphplcoptimizationandapplicationtopharmacokineticstudy AT somnathbhinge meloxicamquantificationinrabbitplasmabyrphplcoptimizationandapplicationtopharmacokineticstudy |
_version_ |
1724459046415630336 |